Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Hamilton Thorne Ltd. (T:HTL)

Business Focus: Advanced Medical Equipment & Technology (NEC)

Dec 21, 2023 08:45 am ET
Hamilton Thorne Appoints Dr. Ekaterina (Kate) Torchilin as President and CEO
Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced the appointment, of Dr. Ekaterina...
Nov 13, 2023 08:45 am ET
Hamilton Thorne Reports Revenue for the Quarter and Nine Months Ended September 30, 2023
Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported audited financial results for the...
Nov 07, 2023 04:30 pm ET
Hamilton Thorne to Announce Q3 2023 Financial Results and Hold Conference Call on November 13, 2023
Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its financial...
Oct 16, 2023 06:46 pm ET
RETRANSMISSION: Lytham Partners Announces KOL Panels and Participating Companies for its Fall 2023 Investor Conference
Phoenix, Arizona and New York, New York--(Newsfile Corp. - October 16, 2023) - Lytham Partners, a leading investor relations firm, today announced the schedule for its Fall 2023 Investor Conference taking place virtually on October 17, 2023. 50+ companies will be available for virtual 1x1 meetings and select companies will participate in webcast presentations.
Oct 10, 2023 11:29 am ET
Canadian Investment Regulatory Organization Trade Resumption - HTL
TORONTO, Oct. 10, 2023 /CNW/ - Trading resumes in:
Oct 10, 2023 11:13 am ET
Hamilton Thorne Announces the Acquisition of Gynetics Medical Products N.V.
Beverly, Massachusetts and Toronto, Ontario--(Newsfile Corp. - October 10, 2023) - Hamilton Thorne Ltd. (TSX: HTL) ("Hamilton Thorne" or the "Company"), a leading provider of precision instruments, consumables, software, and services to the Assisted Reproductive Technologies ("ART") research and cell biology markets, today announced that it has completed the acquisition (the "Transaction") of Gynetics Medical Products, N.V. and Gynetics Services B.V. (collectively, "Gynetics").
Oct 10, 2023 08:36 am ET
Canadian Investment Regulatory Organization Trading Halt - HTL
TORONTO, Oct. 10, 2023 /CNW/ - The following issues have been halted by CIRO:
Sep 21, 2023 11:27 am ET
Hamilton Thorne Ltd. Opens the Market
TORONTO, Sept. 21, 2023 /CNW/ - David Wolf, Chairman and Chief Executive Officer, Hamilton Thorne Ltd. (TSX: HTL) joined Dani Lipkin, Managing Director, Global Innovation Sector, Toronto Stock Exchange (TSX), to open the market and celebrate the Company's graduation from TSX Venture Exchange to Toronto Stock Exchange.
Sep 21, 2023 11:27 am ET
Hamilton Thorne Ltd. Opens the Market
TORONTO, Sept. 21, 2023 /PRNewswire/ - David Wolf, Chairman and Chief Executive Officer, Hamilton Thorne Ltd. (TSX: HTL) joined Dani Lipkin, Managing Director, Global Innovation Sector, Toronto Stock Exchange (TSX), to open the market and celebrate the Company's graduation from TSX Venture Exchange to Toronto Stock Exchange.
Sep 06, 2023 08:30 am ET
Hamilton Thorne Graduating to Toronto Stock Exchange Main Board
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced its graduation from the TSX...
Aug 21, 2023 03:17 pm ET
TSX Venture Exchange, Hamilton Thorne Ltd., View From The C-Suite
TORONTO, Aug. 21, 2023 /CNW/ - David Wolf, Chief Executive Officer, Hamilton Thorne Ltd. (TSXV: HTL) shares his Company's story in an interview with TMX Group.
Aug 17, 2023 08:45 am ET
Hamilton Thorne Reports Revenue For The Quarter And Six Months Ended June 30, 2023
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported audited financial results for the...
Aug 10, 2023 08:30 am ET
Hamilton Thorne to Announce Q2 2023 Financial Results and Hold Conference Call on August 17, 2023
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its...
May 15, 2023 08:30 am ET
Hamilton Thorne Reports Record Revenue for the Quarter Ended March 31, 2023
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported financial results for the quarter...
May 08, 2023 08:30 am ET
Hamilton Thorne to Announce Q1 2023 Financial Results and Hold Conference Call on May 15, 2023
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its...
Apr 13, 2023 08:30 am ET
Hamilton Thorne to Participate in Bloom Burton & Co. Healthcare Investor Conference on April 25-26, 2023
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that the Company will...
Mar 30, 2023 08:30 am ET
Hamilton Thorne Reports Record Revenue and EBITDA for the Quarter and Year Ended December 31, 2022
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported audited financial results for the...
Mar 23, 2023 08:30 am ET
Hamilton Thorne to Announce Q4 and Year End 2022 Financial Results and Hold Conference Call on March 30, 2023
Hamilton Thorne Ltd. (TSX-V:HTL), a leading global provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its...
Feb 16, 2023 08:30 am ET
Hamilton Thorne Announces Record Revenue and Adjusted EBITDA for the Quarter and Year Ended December 31, 2022
Hamilton Thorne Ltd. (TSX-V:HTL), a leading global provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported preliminary selected...
Jan 24, 2023 01:58 pm ET
Hamilton Thorne Announces Passing of Diarmaid Douglas-Hamilton
Hamilton Thorne Ltd. (TSX-V: HTL) ("Hamilton Thorne" or the "Company"), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies ("ART") research, and cell biology markets, today...
Dec 01, 2022 07:30 am ET
Hamilton Thorne Announces the Acquisition of Microptic, S.L.
Hamilton Thorne Ltd. (TSX-V: HTL) ("Hamilton Thorne" or the "Company"), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies ("ART") research, and cell biology markets, today...
Nov 22, 2022 08:00 am ET
Hamilton Thorne Reports Financial and Operational Results for the Quarter and Nine Months Ended September 30, 2022
Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported financial and operational results...
Nov 08, 2022 11:05 am ET
Hamilton Thorne to Announce Q3 Financial Results and Hold Conference Call on November 22, 2022
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its...
Sep 02, 2022 08:30 am ET
Hamilton Thorne to Participate in the 6th Annual Lake Street Capital Markets Best Ideas Growth Conference
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that the Company will...
Aug 23, 2022 08:05 am ET
Hamilton Thorne Reports Financial and Operational Results for the Quarter and Six Months Ended June 30, 2022
Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported financial and operational results...
Aug 16, 2022 06:29 pm ET
Hamilton Thorne to Announce Q2 Financial Results and Hold Conference Call on August 23, 2022
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its...
Jul 27, 2022 08:30 am ET
Hamilton Thorne to Present at Canaccord Genuity 42nd Annual Growth Conference
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that David Wolf, President and...
Jul 12, 2022 08:30 am ET
Hamilton Thorne Appoints Francesco Fragasso as CFO
Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced the appointment of Francesco...
Jun 15, 2022 08:30 am ET
Hamilton Thorne Announces Annual and Special Meeting Voting Results
Hamilton Thorne Ltd. (TSX-V: HTL) (“Hamilton Thorne” or the “Company”), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, is pleased...
May 19, 2022 08:15 am ET
Hamilton Thorne Reports Financial and Operational Results for the Quarter-Ended March 31, 2022
Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported financial and operational results...
May 11, 2022 01:47 pm ET
CORRECTING and REPLACING - Hamilton Thorne Ltd.
In a press release issued earlier today by Hamilton Thorne Ltd. (TSX-V: HTL), we were informed the headline of the release should read "Hamilton Thorne to Announce Q1 2022 Financial Results and Hold Conference Call on May 19, 2022" instead of...
May 11, 2022 09:24 am ET
Hamilton Thorne to Announce Q4 and Year End 2021 Financial Results and Hold Conference Call on May 19, 2022
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its...
Apr 13, 2022 08:15 am ET
Hamilton Thorne to Participate in Bloom Burton & Co. Healthcare Investor Conference on May 2-3, 2022
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that the Company will...
Apr 07, 2022 08:15 am ET
Hamilton Thorne Reports Record Revenue and EBITDA for the Quarter and Year Ended December 31, 2021
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported audited financial results for the...
Mar 31, 2022 08:15 am ET
Hamilton Thorne to Announce Q4 and Year End 2021 Financial Results and Hold Conference Call on April 7, 2022
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its...
Feb 17, 2022 08:15 am ET
Hamilton Thorne Announces Record Revenue for the Quarter and Year Ended December 31, 2021
Hamilton Thorne Ltd. (TSX-V:HTL), a leading global provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported preliminary selected...
Jan 18, 2022 08:15 am ET
Hamilton Thorne Appoints Karen Firestone to Board of Directors
Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it has appointed Karen...
Nov 22, 2021 08:15 am ET
Hamilton Thorne Reports Financial and Operational Results for the Quarter-Ended September 30, 2021
Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported unaudited financial and...
Nov 17, 2021 07:00 am ET
Hamilton Thorne to Present at Stifel and Piper Sandler Conferences
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will be presenting at...
Nov 15, 2021 08:15 am ET
Hamilton Thorne to Announce Q3 2021 Financial Results and Hold Conference Call on November 22, 2021
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its...
Nov 04, 2021 05:00 pm ET
FAX Capital Corp. Reports Third Quarter 2021 Results
FAX Capital Corp. (FAX Capital or the Company) (TSX: FXC and FXC.WT) today announced its results for the quarter ended September 30, 2021. All currency figures are Canadian dollars. Despite heightened market volatility in the period, the Company...
Oct 13, 2021 04:47 pm ET
Hamilton Thorne Equity Grants Under Its Long-Term Equity Incentive Plan
Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it has issued incentive...
Aug 18, 2021 08:15 am ET
Hamilton Thorne Reports Financial and Operational Results for the Quarter-Ended June 30, 2021
Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported unaudited financial and...
Aug 11, 2021 08:20 am ET
Hamilton Thorne to Announce Q2 2021 Financial Results and Hold Conference Call on August 18, 2021
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its...
Aug 04, 2021 05:00 pm ET
FAX Capital Corp. Reports Second Quarter 2021 Results
FAX Capital Corp. (FAX Capital or the Company) (TSX: FXC and FXC.WT) today announced its results for the quarter ended June 30, 2021. All currency figures are Canadian dollars. The Company performed well during the period, and these results...
Aug 04, 2021 08:20 am ET
Hamilton Thorne to Present at Canaccord Genuity 41st Annual Growth Conference
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that David Wolf, President and...
Jul 27, 2021 08:00 am ET
Hamilton Thorne Announces the Increase of Its Bank Lines of Credit to US$12.5 Million
Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software, and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported that it has converted the recent...
Jul 15, 2021 07:32 am ET
Hamilton Thorne Announces the Acquisition of IVFTECH ApS and K4 Technology ApS
Hamilton Thorne Ltd. (TSX-V: HTL) ("Hamilton Thorne" or the "Company"), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) research, and cell biology markets, today...
May 25, 2021 08:15 am ET
Hamilton Thorne Reports Financial and Operational Results for the Quarter-Ended March 31, 2021
Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported financial and operational results...
May 18, 2021 08:20 am ET
Hamilton Thorne to Announce Q1 2021 Financial Results and Hold Conference Call on May 25, 2021
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its...
May 04, 2021 08:20 am ET
Hamilton Thorne Announces the Acquisition of Tek-Event Pty Ltd.
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it has completed the...
Apr 15, 2021 08:20 am ET
Hamilton Thorne Announces Dr. Thomas Ebner and Cynthia Hudson to Join Its Scientific Advisory Board
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced the strengthening of its...
Apr 13, 2021 08:20 am ET
Hamilton Thorne to Participate in Bloom Burton & Co. Healthcare Investor Conference on April 20-21, 2021
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that the company will...
Apr 08, 2021 08:15 am ET
Hamilton Thorne Reports Record Revenue for the Quarter and Year Ended December 31, 2020
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported audited financial results for the...
Apr 01, 2021 12:10 pm ET
Hamilton Thorne to Announce Q4 and Year End 2020 Financial Results and Hold Conference Call on April 8, 2021
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its...
Feb 24, 2021 08:20 am ET
Hamilton Thorne to Participate in Oppenheimer Annual Healthcare Conference on March 17, 2021
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that management will participate...
Feb 18, 2021 08:15 am ET
Hamilton Thorne Announces Record Revenue for the Quarter and Year Ended December 31, 2020
Hamilton Thorne Ltd. (TSX-V:HTL), a leading global provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported preliminary selected...
Feb 09, 2021 08:20 am ET
Hamilton Thorne Appoints Feng Han to Board of Directors
Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it has appointed Feng Han to...
Jan 19, 2021 08:30 am ET
FAX Capital Announces Addition of Marc Robinson to Board of Hamilton Thorne Ltd., a FAX portfolio investment
FAX Capital Corp. (the “Company”) (TSX: FXC and FXC.WT) is pleased to announce that Marc Robinson, the Company’s Managing Director, Investments, has been appointed to the board of directors of Hamilton Thorne Ltd. (TSXV: HTL) (“Hamilton Thorne”),...
Jan 19, 2021 08:15 am ET
Hamilton Thorne Appoints Marc Robinson to Board of Directors
Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it has appointed Marc...
Nov 19, 2020 08:10 am ET
Hamilton Thorne Reports Financial and Operational Results for the Quarter and Nine Months Ended September 30, 2020
Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported unaudited financial and...
Nov 18, 2020 08:25 am ET
HamiltonThorne to Participate in Piper Sandler Healthcare Conference on December 1-3, 2020
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that management will participate...
Nov 12, 2020 08:25 am ET
Hamilton Thorne to Announce Q3 2020 Financial Results and Hold Conference Call on November 19, 2020
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its...
Nov 04, 2020 12:30 pm ET
Hamilton Thorne to Participate in Oppenheimer Fall MedTech Summit on November 12, 2020
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that management will participate...
Sep 02, 2020 08:30 am ET
Hamilton Thorne to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that David Wolf, President and...
Aug 27, 2020 08:30 am ET
Hamilton Thorne to Present at the Baird 2020 Global Healthcare Conference
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that David Wolf, President and...
Aug 20, 2020 08:20 am ET
Hamilton Thorne Reports Financial and Operational Results for the Quarter-Ended June 30, 2020
Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported unaudited financial and...
Aug 13, 2020 08:25 am ET
Hamilton Thorne to Announce Q2 2020 Financial Results and Hold Conference Call on August 20, 2020
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its...
Aug 10, 2020 09:00 am ET
Hamilton Thorne to Present at Canaccord Genuity 40th Annual Growth Conference
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that David Wolf, President and...
Aug 06, 2020 05:06 pm ET
FAX Capital Corp. Reports Second Quarter 2020 Results
FAX Capital Corp. (FAX Capital or the Company) (TSX: FXC and FXC.WT) today announced its results for the second quarter of 2020.  Operating Highlights: Deployed $27.8 million of capital during the quarter into four public company investments:...
Jun 01, 2020 09:00 am ET
Fax Capital Announces Additional Investment in Hamilton Thorne Ltd., Files Early Warning Report
FAX Capital Corp. (FAX or the Company) (TSX: FXC & FXC.WT) is pleased to announce that it has acquired ownership of an additional 3,182,000 common shares (the Shares) of Hamilton Thorne Ltd. (Hamilton Thorne) (TSXV:HTL) through a non-brokered...
May 29, 2020 09:47 am ET
Hamilton Thorne Announces Closing of $7.0 Million Private Placement Financing
Hamilton Thorne Ltd. (TSX-V: HTL) (“Hamilton Thorne” or the “Company”), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, is pleased...
May 28, 2020 04:30 pm ET
Hamilton Thorne Reports Financial and Operational Results for the Quarter-Ended March 31, 2020
Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported financial and operational results...
May 26, 2020 10:54 am ET
Hamilton Thorne to Announce Q1 2020 Financial Results on May 28 and Hold Conference Call on May 29, 2020
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its...
May 15, 2020 08:12 am ET
FAX Capital Corp. Introduces Initial Investments and Reports First Quarter 2020 Results
FAX Capital Corp. (FAX Capital or the Company) (TSX: FXC & FXC.WT) today introduced its initial investments and announced its results for the three months ended March 31, 2020.  Operating Highlights: Deployed $35.3 million of capital during the...
Apr 28, 2020 08:00 am ET
Hamilton Thorne Announces Full Conversion of Outstanding Debentures
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that, in accordance with their...
Apr 22, 2020 08:15 am ET
Hamilton Thorne Reports Record Revenue for the Quarter and Year-Ended December 31, 2019
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported audited financial results for the...
Apr 15, 2020 08:25 am ET
HAMILTON THORNE to announce Q4 and year-ended 2019 financial results and hold conference call on April 22, 2020
Hamilton Thorne Ltd. (TSX-V: HTL), a leading worldwide provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release...
Mar 24, 2020 08:42 am ET
Hamilton Thorne Statement Regarding the Impact of COVID-19
Hamilton Thorne Ltd. (TSX-V:HTL), a leading global provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today provided an update on the...
Feb 19, 2020 08:20 am ET
Hamilton Thorne Announces Record Revenue and EBITDA for the Quarter and Year Ended December 31, 2019
Hamilton Thorne Ltd. (TSX-V:HTL), a leading global provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today reported preliminary selected...
Feb 12, 2020 04:35 pm ET
Hamilton Thorne to Host Investor Webcast on February 25, 2020
Hamilton Thorne Ltd. (TSX-V: HTL), a leading worldwide provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today announced that it will...
Nov 25, 2019 04:30 pm ET
Hamilton Thorne to Present at Piper Jaffray’s 31st Annual Healthcare Conference
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today announced that David Wolf,...
Nov 21, 2019 08:15 am ET
Hamilton Thorne Reports Record Revenue and Adjusted EBITDA for the Quarter and Nine Months Ended September 30, 2019
Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today reported financial and operational...
Nov 14, 2019 05:26 pm ET
Hamilton Thorne to Announce Q3 2019 Financial Results and Hold Conference Call on November 21, 2019
Hamilton Thorne Ltd. (TSX-V: HTL), a leading worldwide provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today announced that it will...
Oct 31, 2019 08:30 am ET
Hamilton Thorne to Present at the 2019 Canaccord Genuity Health and Wellness Investor Day
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today announced that David Wolf,...
Oct 15, 2019 08:30 am ET
Hamilton Thorne Announces Additional Accreditations for Its Embryotech Laboratories Subsidiary
Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today reported that its Embryotech...
Sep 30, 2019 05:38 pm ET
Hamilton Thorne Announces US$7.5 Million Line of Credit
Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today reported that it has expanded its...
Sep 10, 2019 08:30 am ET
Hamilton Thorne Announces FDA Clearance for First Media Product in the US and European CE Marks Issued for Specialty Media
Hamilton Thorne Ltd. (TSX-V:HTL), a leading worldwide provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today announced that the US Food...
Aug 27, 2019 08:20 am ET
Hamilton Thorne Reports Financial and Operational Results for the Quarter-Ended June 30, 2019
Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today reported financial and operational...
Aug 20, 2019 08:30 am ET
Hamilton Thorne to Announce Q2 2019 Financial Results and Hold Conference Call on August 27, 2019
Hamilton Thorne Ltd. (TSX-V: HTL), a leading worldwide provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today announced that it will...
Aug 13, 2019 08:01 am ET
Hamilton Thorne Announces the Acquisition of Planer Ltd.
Hamilton Thorne Ltd. (TSX-V: HTL) ("Hamilton Thorne" or the "Company"), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies ("ART") and developmental biology research markets,...
Jun 27, 2019 04:15 pm ET
Hamilton Thorne Announces Partial Debenture Conversion
Hamilton Thorne Ltd. (TSX-V:HTL), a leading worldwide provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today announced that the holders...
May 23, 2019 08:35 am ET
Hamilton Thorne Reports Financial and Operational Results for the Quarter-Ended March 31, 2019
Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today reported financial and operational...
May 17, 2019 01:30 pm ET
Hamilton Thorne to Announce Q1 2019 Financial Results and Hold Conference Call on May 23, 2019
Hamilton Thorne Ltd. (TSX-V: HTL), a leading worldwide provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today announced that it will...
May 01, 2019 04:30 pm ET
Hamilton Thorne Announces the Introduction of LYKOS DTS™ Dynamic Targeting System for IVF Clinical Market
Hamilton Thorne Ltd. (TSX-V:HTL), a leading worldwide provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today announced the introduction...
Apr 29, 2019 08:00 am ET
Hamilton Thorne Reports Record Revenue for the Quarter and Year-Ended December 31, 2018
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today reported audited financial results...
Apr 22, 2019 12:32 pm ET
Hamilton Thorne to Announce Q4 and Year-End 2018 Financial Results and Hold Conference Call on April 29, 2019
Hamilton Thorne Ltd. (TSX-V: HTL), a leading worldwide provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today announced that it will...
Apr 11, 2019 08:20 am ET
Hamilton Thorne to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference
Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today announced that David Wolf,...
Feb 19, 2019 08:15 am ET
Hamilton Thorne Announces Record Revenue for the Quarter and Year Ended December 31, 2018
Hamilton Thorne Ltd. (TSX-V:HTL), a leading global provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today reported preliminary selected...
Nov 20, 2018 08:25 am ET
Hamilton Thorne Announces Financial and Operational Results for the Quarter Ended September 30, 2018
Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today reported financial and operational...
Nov 15, 2018 04:38 pm ET
Hamilton Thorne Announces US$3 Million Acquisition Line of Credit
Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today reported that it has established a...
Nov 13, 2018 05:58 pm ET
Hamilton Thorne to Announce Q3 2018 Financial Results and Hold Conference Call on November 20, 2018
Hamilton Thorne Ltd. (TSX-V: HTL), a leading worldwide provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today announced that it will...
Sep 14, 2018 09:32 am ET
Hamilton Thorne Announces Completion of CDN $10,000,000 Bought Deal Private Placement
Hamilton Thorne Ltd. (TSX-V:HTL) (“Hamilton Thorne” or the “Company”), a leading worldwide provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research...
Aug 28, 2018 08:21 am ET
Hamilton Thorne Announces CDN $10,000,000 Bought Deal Private Placement
Hamilton Thorne Ltd. (TSX-V:HTL), a leading world-wide provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today announced that it has...
Aug 22, 2018 08:20 am ET
Hamilton Thorne Announces Record Revenue and EBITDA for the Quarter Ended June 30, 2018
Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today reported financial and operational...
Aug 09, 2018 04:15 pm ET
Hamilton Thorne to Announce Q2 2018 Financial Results and Hold Conference Call on August 22, 2018
Hamilton Thorne Ltd. (TSX-V: HTL), a leading worldwide provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today announced that it will...
Jul 19, 2018 04:15 pm ET
Hamilton Thorne Acquires ZANDAIR™ Air Purification Products Business
Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today announced that it has completed the...
Jun 28, 2018 10:34 am ET
Hamilton Thorne Launches New Corporate Website
Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today announced that it is launching a new...
May 24, 2018 08:20 am ET
Hamilton Thorne Reports Financial and Operational Results for the Quarter-ended March 31, 2018
Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today reported financial and operational...
May 18, 2018 05:06 pm ET
Hamilton Thorne to Announce Q1 2018 Financial Results and Hold Conference Call on May 24, 2018
Hamilton Thorne Ltd. (TSXV:HTL), a leading world-wide provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today announced that it will...
May 01, 2018 07:30 am ET
Hamilton Thorne to Present at the 2018 Bloom Burton & Co. Healthcare Investor Conference
BEVERLY, Mass. and TORONTO, May 01, 2018 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today announced that...
Apr 30, 2018 07:30 am ET
Hamilton Thorne Announces the Introduction of Next Generation Software for Its Clinical Laser Systems
New software significantly improves imaging, database connectivity, and ease of use
Apr 26, 2018 03:29 pm ET
Hamilton Thorne to Host Investor Webcast on May 1, 2018
BEVERLY, Mass. and TORONTO, April 26, 2018 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V:HTL), a leading world-wide provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today announced...
Apr 25, 2018 08:20 am ET
Hamilton Thorne Reports Record Revenue and Earnings for the Quarter and Year-Ended December 31, 2017
110% Revenue and 172% Adjusted EBITDA Growth for the Year - 97% Revenue and 43% EBITDA Growth for the Fourth Quarter
Apr 18, 2018 04:33 pm ET
Hamilton Thorne to Announce Q4 and Year-End 2017 Financial Results and Hold Conference Call on April 25, 2018
BEVERLY, Mass. and TORONTO, April 18, 2018 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V:HTL), a leading world-wide provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today announced...
Mar 29, 2018 08:25 am ET
Hamilton Thorne Engages Bristol Capital to Provide Investor Relations and Communications Services
BEVERLY, Mass. and TORONTO, March 29, 2018 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V:HTL), a leading worldwide provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, announced today...
Feb 13, 2018 04:30 pm ET
Hamilton Thorne Announces Record Revenue for the Quarter and Year Ended December 31, 2017
Preliminary Results Highlight 109% Revenue and 168% Adjusted EBITDA Growth for the Year
Nov 21, 2017 04:25 pm ET
Hamilton Thorne Announces 147% Revenue Growth for the Quarter Ended September 30, 2017
Year to date revenues of $14.9 million; Adjusted EBITDA of $3.6 million
Nov 15, 2017 05:19 pm ET
Hamilton Thorne to Announce Q3 2017 Financial Results November 21
Conference Call Scheduled for 11:00 a.m. EST November 22
Aug 16, 2017 11:00 am ET
Hamilton Thorne to announce Q2 2017 financial results and Host conference call on AUGUST 22
BEVERLY, Mass. and TORONTO, Ontario, Aug. 16, 2017 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V:HTL), a leading world-wide provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today announced that it will release its financial results for the three and six months ended June 30, 2017 before the market opens on Tuesday, August 22, 2017. The press release, with accompanying financial information, will be posted on the Company’s website at www.hamiltonthorne.com and on www.sedar.com....
May 23, 2017 12:00 pm ET
Hamilton Thorne And BCSI Announce Distribution Agreement
BEVERLY, Mass. and TORONTO, May 23, 2017 /PRNewswire/ -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services, and Blood Cell Storage, Inc. (BCSI), a world leader in pH sensing technologies, today announced the signing of a distribution agreement for BCSI's SAFE Sens TrakStation® and TrakPod® technology.
Apr 28, 2017 03:55 pm ET
IIROC Trading Resumption - HTL
VANCOUVER, April 28, 2017 /CNW/ - Trading resumes in:
Apr 28, 2017 02:32 pm ET
Hamilton Thorne Announces the Acquisition of Gynemed GmbH & Co. KG and Related Financing Transactions
Hamilton Thorne Ltd. (TSX VENTURE:HTL) ("Hamilton Thorne" or the "Company"), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets...
Apr 28, 2017 02:32 pm ET
Hamilton Thorne Announces the Acquisition of Gynemed GmbH & Co. KG and Related Financing Transactions
Hamilton Thorne Ltd. (TSX VENTURE: HTL) ("Hamilton Thorne" or the "Company"), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets today announced that it has completed the acquisition of Gynemed GmbH & Co. KG ("Gynemed") for total consideration of Euro 13.9 million (approximately US$15.1 million) (the "Transaction").
Apr 27, 2017 09:32 pm ET
Hamilton Thorne Reports Record Revenue Growth for Quarter and Year-Ended December 31, 2016
BEVERLY, Mass. and TORONTO, April 27, 2017 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today reported audited financial results for the fourth quarter and year-ended December 31, 2016....
Apr 27, 2017 05:27 pm ET
IIROC Trading Halt - HTL
VANCOUVER, April 27, 2017 /CNW/ - The following issues have been halted by IIROC:
Mar 23, 2017 04:32 pm ET
Hamilton Thorne Releases New and Improved DIMENSIONS II V 3.0 Strict Morphology Software
BEVERLY, Mass. and TORONTO, March 23, 2017 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets announced today the release of its new DIMENSIONS™ II Version 3.0 Strict Morphology software module for its CASA II line of automated sperm analysis systems. Focusing on ease of use plus interoperability and consistency with the Company’s other software products, DIMENSIONS II is fully compatible with Hamilton Thorne’s IVOS II...
Sep 20, 2016 11:05 am ET
IIROC Trading Resumption - HTL
VANCOUVER, Sept. 20, 2016 /CNW/ - Trading resumes in:
Sep 19, 2016 12:42 pm ET
IIROC Trading Halt - HTL
VANCOUVER, Sept. 19, 2016 /CNW/ - The following issues have been halted by IIROC: